• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 8, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume8, Issue3

Alopecia Areata Updated Management: Minoxidil Solution 5% and Microneedling with Anthralin Cream 1%.

    HendDarwishGamil,Heba Mohamed Abdelatif,Mohammed HamedKhater

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 3, Pages 3738-3749

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Alopecia Areata (AA) is an autoimmune disease of the hair follicle that presents as
non-scarring alopecia both in the scalp and non-scalp areas. The etiology of this disease remains
unknown ;however, a current hypothesis implicates T-cell-mediated autoimmunity that affects hair
follicles, as well as the up- regulation of inflammatory cytokines ,in the pathogenesis of disease
.The severity ranges from focal (patch-type AA) to total scalp hair loss (alopecia totalis) to entire
body hair loss (alopecia universalis).Microneedling (MN), also known as collagen induction
therapy, is a process involving repetitive puncturing of the skin with sterilized microneedles. Its
original conception can be traced back to 2012, when Orentreich and Orentreich developed the
concept of “subcision” or using hypodermic needles to induce wound healing in depressed
cutaneous scars. Anthralin is used in alopecia areata at concentrations ranging from 0.5 to 1 % for
20-30 minutes after which the scalp should be washed with shampoos in order to avoid excessive
irritation.Minoxidil stimulates hair growth only in cases of mild AA, but slight to no effects were
observed in patients with extensive AA. Only mild side effects of minoxidil were reported with no
evidence of systemic effects
Keywords:
    Alopecia Areata (A.A) Microneedling Minoxidil Anthralin
  • PDF (533 K)
  • XML
(2021). Alopecia Areata Updated Management: Minoxidil Solution 5% and Microneedling with Anthralin Cream 1%.. European Journal of Molecular & Clinical Medicine, 8(3), 3738-3749.
HendDarwishGamil,Heba Mohamed Abdelatif,Mohammed HamedKhater. "Alopecia Areata Updated Management: Minoxidil Solution 5% and Microneedling with Anthralin Cream 1%.". European Journal of Molecular & Clinical Medicine, 8, 3, 2021, 3738-3749.
(2021). 'Alopecia Areata Updated Management: Minoxidil Solution 5% and Microneedling with Anthralin Cream 1%.', European Journal of Molecular & Clinical Medicine, 8(3), pp. 3738-3749.
Alopecia Areata Updated Management: Minoxidil Solution 5% and Microneedling with Anthralin Cream 1%.. European Journal of Molecular & Clinical Medicine, 2021; 8(3): 3738-3749.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 148
  • PDF Download: 746
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus